Compound index

Coenzymes & Antioxidants

Cyanocobalamin

Also known as Vitamin B12

FDA-approved for specific indicationsFDA-approved

Last reviewed: 2026-11-19

Evidence status & limitations

Specific approved medicines address vitamin B12 deficiency; evidence in deficiency is not evidence of extra benefit in people with normal B12 status.

Regulatory status

FDA approval applies only to the named products and indications below. It does not approve every formulation or other use.

  • Nascobal · Vitamin B12 Deficiency

    Specified adult B12-deficiency treatment or prevention and maintenance of pernicious-anemia remission without nervous-system involvement, under the product’s labeled conditions.

    Authoritative label record

Status as of 2026-11-19. Regulations change. Check FDA.gov for current information.

WADA prohibited status: current list and context

Known risks & open questions

Allergic reactions are possible; neurological symptoms need evaluation rather than assumed vitamin deficiency.

Key sources

Indication-specific regulatory sources and editorial screen checked November 19, 2026. This is not an exhaustive systematic review; consult current labels.

Related compounds

Related glossary terms